Cargando…
PP2Ac/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophages
Stimulator of IFN genes type I (STING-Type I) IFN signaling in myeloid cells plays a critical role in effective antitumor immune responses, but STING agonists as monotherapy have shown limited efficacy in clinical trials. The mechanisms that downregulate STING signaling are not fully understood. Her...
Autores principales: | Ho, Winson S., Mondal, Isha, Xu, Beisi, Das, Oishika, Sun, Raymond, Chiou, Pochin, Cai, Xiaomin, Tahmasebinia, Foozhan, McFadden, Elizabeth, Wu, Caren Yu-Ju, Wu, Zhihao, Matsui, William, Lim, Michael, Meng, Zhipeng, Lu, Rongze Olivia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014107/ https://www.ncbi.nlm.nih.gov/pubmed/36757811 http://dx.doi.org/10.1172/JCI162139 |
Ejemplares similares
-
Anaphylaxis from Wasp Stings Inducing Coronary Thrombus
por: Kasim, Sazzli, et al.
Publicado: (2012) -
Identification of a Recurrent STRN/ALK Fusion in Thyroid Carcinomas
por: Pérot, Gaëlle, et al.
Publicado: (2014) -
Silencing of STRN4 suppresses the malignant characteristics of cancer cells
por: Wong, Meihong, et al.
Publicado: (2014) -
STRN-ALK, A Novel In-Frame Fusion With Response to Alectinib
por: Nagasaka, Misako, et al.
Publicado: (2020) -
STRN-ALK Fusion–Positive Case of Breast Cancer With Response to Alectinib
por: Kelly, Andrew D., et al.
Publicado: (2021)